As a trusted clinical research organization (CRO) with an on site phase 1 clinical pharmacology unit for human abuse potential (HAP) trials, Dr. Vince Clinical Research is relied upon by sponsors to conduct these trials with a high degree of precision and accuracy....
Representing Dr. Vince Clinical Research, Dr. Toni Grant, Director of Pharmacokinetics, presented “Optimizing Pharmacokinetics in Clinical Development” at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2025 Annual Meeting in Washington, D.C....
Dr. Vince Clinical Research is a trusted contract research organization (CRO) for human abuse potential (HAP) trials. We understand the importance of early and consistent engagement with the FDA’s Controlled Substance Staff (CSS) to maintain regulatory compliance and...
Experience Dr. George Atiee of Dr. Vince Clinical Research presenting “Medical Monitoring Oversight and Real-Time Data Access,” where he highlights the significance of accessing safety data and its ongoing analysis through remote accessible devices. This presentation...
As a leading contract research organization (CRO) for human abuse potential (HAP) trials, Dr. Vince Clinical Research has expertise in the creation and implementation of positive control groups. By following well-defined protocols, DVCR produces optimized results for...
As the leading CRO for Human Abuse Potential (HAP) studies, Dr. Vince Clinical Research has significant operational expertise in the conduct of these complex clinical trials where volunteer safety is paramount. Our clinical safety team is comprised of Advanced...
Recent Comments